Current trends in prostate cancer diagnosis and staging among United States urologists

被引:39
作者
Plawker, MW [1 ]
Fleisher, JM [1 ]
Vapnek, EM [1 ]
Macchia, RJ [1 ]
机构
[1] SUNY HLTH SCI CTR,DEPT PREVENT MED & COMMUNITY HLTH,BROOKLYN,NY 11203
关键词
prostatic neoplasms; diagnosis; prostate-specific antigen;
D O I
10.1016/S0022-5347(01)64145-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We analyzed current practice patterns and determined whether urologists are diagnosing and staging prostate cancer in accordance with one another and with available literature. Materials and Methods: An anonymous questionnaire was mailed to 1,500 randomly selected practicing American Urological Association members throughout the United States, categorized according to practice setting and decade of residency training completion. Results: There were 624 respondents (41.6%). Annual routine prostate cancer detection is being aimed toward the right of the age spectrum. More than half of respondents use age specific prostate specific antigen (PSA), while fewer than half use PSA density in determining need for biopsy. The vast majority will perform radical prostatectomy on patients whose age suggests that they will not benefit from surgery. High PSA values and Gleason scores often are disregarded as independent precluding factors when deciding to perform radical prostatectomy. Computerized tomography and radionuclide bone imaging are used routinely far in excess of what the literature suggests is appropriate. Regardless of preoperative staging results, most urologists still perform lymphadenectomy with all radical prostatectomies. Conclusions: Discrepancies exist in practice patterns between urologists as well as inconsistencies in logic within individuals. There is little variation between individuals in different practice settings. Our results reflect the often confusing and conflicting data published during the last decade.
引用
收藏
页码:1853 / 1858
页数:6
相关论文
共 49 条
[21]  
Gerber GS, 1996, JAMA-J AM MED ASSOC, V276, P615
[22]   Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer [J].
Gleave, ME ;
Coupland, D ;
Drachenberg, D ;
Cohen, L ;
Kwong, S ;
Goldenberg, SL ;
Sullivan, LD .
UROLOGY, 1996, 47 (05) :708-712
[23]   SYSTEMATIC SEXTANT BIOPSIES IN 651 PATIENTS REFERRED FOR PROSTATE EVALUATION [J].
HAMMERER, P ;
HULAND, H .
JOURNAL OF UROLOGY, 1994, 151 (01) :99-102
[24]   RANDOM SYSTEMATIC VERSUS DIRECTED ULTRASOUND GUIDED TRANS-RECTAL CORE BIOPSIES OF THE PROSTATE [J].
HODGE, KK ;
MCNEAL, JE ;
TERRIS, MK ;
STAMEY, TA .
JOURNAL OF UROLOGY, 1989, 142 (01) :71-75
[25]   CLINICAL USE OF PROSTATE SPECIFIC ANTIGEN IN PATIENTS WITH PROSTATE-CANCER [J].
HUDSON, MA ;
BAHNSON, RR ;
CATALONA, WJ .
JOURNAL OF UROLOGY, 1989, 142 (04) :1011-1017
[26]   EXPERIENCE WITH GLEASON HISTOPATHOLOGIC GRADING IN PROSTATIC-CANCER [J].
KRAMER, SA ;
SPAHR, J ;
BRENDLER, CB ;
GLENN, JF ;
PAULSON, DF .
JOURNAL OF UROLOGY, 1980, 124 (02) :223-225
[27]  
LANGE PH, 1989, J UROLOGY, V141, P873
[28]   INDICATIONS FOR ULTRASOUND-GUIDED TRANSITION ZONE BIOPSIES IN THE DETECTION OF PROSTATE-CANCER [J].
LUI, PD ;
TERRIS, MK ;
MCNEAL, JE ;
STAMEY, TA .
JOURNAL OF UROLOGY, 1995, 153 (03) :1000-1003
[29]   Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia [J].
McNeal, J ;
Noldus, J .
UROLOGY, 1996, 48 (05) :751-756
[30]  
OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V269, P57